1Sheare GM,Molecular Medicine:Cytokines in health and diseases[J].J Inflammation 1996, 46( 1) ; 61 -63.
2Elhage R.Maret A.Pieraggi MT.et al.Differenatial effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fattystreak formation in apolipoprotein E-deficient mice[J].Circulation 1998,97(3) : 242-244.
3Engler D.Use of vascular endothelial growth facotr for therapeutic andgiogenesis[J].Cirulation 1996.94(7):1496-1498.
4Kamijo R.Gerecitano J.Shapiro D.et al.Genet of nitro oxide and clearance of interferon-γ after BCG infection are impired in mice that lack the interferon-γ receptor[J].J Inflammation 1996,46(1):23-31.
5Torre-Amion G.Kapdia S.Lee J.et al.Tumour necrosis factor-α and tumor necrosis factor receptor in the failing human heart[J].Circulation 1996,93(4) :704-711.
6Flyno JL.Goldstein MM.Chan J.et al.Tumour necrosis factor-α is require in the protective immune response against Mycobacterium tuber culosis in mice[J].Immunity 1995,2(6 ):561-572.
7Ono K.Matsumori A.Shioi T.et al,Cytokine gene expression after myocardial infarction in rat beart[J].Circulation 1998,98(2):149-156.
8Bozkurk B.Kribbs SB.Clubb FJ.et al.Pathaphysiologically relevant concentrations of tumor necrosis factor-α pramote progression left ventricular dysfunction and remodeling in rats[J].Circulation.1998.97(14):1382-1391.
9Waltenberger J,Mary U.Pents S.et al.Functional upregulation of the enodthelial grwoth factor receptor kdr by hypoxla[J].Circulation.1996.94(7):1467-1654.
10Bristow M,Tumor necrosis factor-α and cardiomyopath[J].Circulation,1998.97(14):1304-1341.
